IRadimed Corporation Financials

Market Capitalization $785.8 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	33.11
Forward PE	26.14
Price to Sales TTM	$8.35
Price to Book MRQ	$7.44
Enterprise to Revenue	7.73
Enterprise to EBITDA	24.23

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	26.48%
Operating Margin	26.98%
Return on Assets TTM	15.87%
Return on Equity TTM	25.52%

Income Statement

Revenue TTM	$67,685,328
Revenue per Share TTM	$5.36
Quarterly Revenue Growth	13.70%
Gross Profit TTM	$50,158,269
EBITDA	$20,800,634
Net Income to Common TTM	$17,923,244
Diluted EPS TTM	$1.35
Quarterly Earnings Growth YoY	21.40%

Balance Sheet

Total Cash MRQ	$45,126,676
Total Cash per Share MRQ	$3.56
Total Debt MRQ	$
Total Debt to Equity MRQ	2.55
Current Ratio MRQ	9.44
Book Value per Share MRQ	$6.01

Cash Flow

Operating Cash Flow TTM	$12,702,073
Levered Free Cash Flow TTM	$6,760,349

IRMD Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	12,644,200
Float Shares	6,529,147
Avg 10 Volume	56,055
Avg 30 Volume	None
Shares Short	104,883
Short Ratio	2.35
Short % of Shares	1.32%
% Held by Insiders	37.04%
% Held by Institutions	55.10%

Stock Price Summary

Beta	0.86
Fifty Two Week Low	$36.12
Fifty Two Week High	$51.04
Fifty Two Week Change	-6.35%
Day 50 MA	$42.53
Day 200 MA	$43.81

Dividends and Splits

Forward Annual Dividend Rate	$2.52
Forward Annual Dividend Yield	5.64%
Trailing Annual Dividend Rate	$0.63
Trailing Annual Dividend Yield	1.41%
Payout Ratio	11.11%
Dividend Date	2024-01-12
Ex Dividend Date	2024-05-17
Last Split Factor
Last Split Date